IN THE NEWS

Inhalation

Ritedose, the Leading Pharmaceutical Manufacturer (CDMO) Specializing in Sterile Blow-Fill-Seal, Expands its BFS Capacity to Meet the Growing Demand for Ophthalmic and Respiratory Medications

COLUMBIA, S.C. June 20, 2024 – The Ritedose Corporation (Ritedose), the leading contract development and manufacturing organization (CDMO) specializing in sterile Blow Fill Seal (BFS) production, announces a significant expansion of its production capabilities to meet the demand for ophthalmic…
READ MORE

Ritedose Reaches Milestone with Asset Purchase

COLUMBIA, S.C.—The Ritedose Corporation, LLC now offers the most complete nebulized inhalation drug portfolio in the industry with the purchase of the Arformoterol Tartrate asset from PAI Pharma of Greenville, S.C. (more…)
READ MORE
FEATURED NEWS
RECEIVE THE LATEST NEWS

Get a healthy dose of all things Ritedose. Subscribe now for breaking news alerts, updates, previews, and more.

Please enter a valid email address.
TAGS CLOUD

Tags

Albuterol ApiJect Arformoterol Tartrate Benedict College BFS Careers CDMO Charitable Community COVID-19 Dispensary of Hope Distribution Center Donation Education Expansion Formoterol Fumarate Generics Give Back Harvest Hope Health Science Homeless No More of Columbia Inhalation Injectables Innovation Liquid Manufacturing Medication Newberry College Novo Group Novo Holdings Novo Nordisk Novozymes Opthalmic Oral PAI Pharma Performance Parkway Pharmaceuticals Respiratory RISE Solutions STEM SuredoseRx United Way Vaccines Workforce Development

Accessibility